ARCELLX INC's ticker is and the CUSIP is 03940C100. A total of 168 filers reported holding ARCELLX INC in Q2 2024. The put-call ratio across all filers is 1.00 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $17,129,982 | -7.2% | 310,382 | +16.9% | 0.01% | -28.6% |
Q1 2024 | $18,459,265 | +155.6% | 265,410 | +103.9% | 0.01% | +133.3% |
Q4 2023 | $7,222,549 | +8.5% | 130,136 | -29.9% | 0.00% | 0.0% |
Q3 2023 | $6,659,076 | +1202.0% | 185,593 | +1018.0% | 0.00% | – |
Q2 2023 | $511,446 | 0.0% | 16,600 | 0.0% | 0.00% | – |
Q1 2023 | $511,446 | +20.5% | 16,600 | +21.2% | 0.00% | – |
Q4 2022 | $424,426 | – | 13,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SR ONE CAPITAL MANAGEMENT, LP | 3,146,630 | $174,637,965 | 73.33% |
NEA Management Company, LLC | 3,745,262 | $207,862,041 | 13.85% |
Paradigm Biocapital Advisors LP | 3,658,624 | $203,053,632 | 9.51% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,435,974 | $135,196,557 | 6.11% |
Perceptive Advisors | 4,544,809 | $252,236,900 | 5.63% |
STEMPOINT CAPITAL LP | 313,604 | $17,405,022 | 4.64% |
Cormorant Asset Management, LP | 1,700,000 | $94,350,000 | 4.51% |
Samsara BioCapital, LLC | 460,441 | $25,554,476 | 3.98% |
Affinity Asset Advisors, LLC | 340,000 | $18,870,000 | 3.45% |
ACUTA CAPITAL PARTNERS, LLC | 77,000 | $4,273,500 | 2.41% |